Evidence map›Paper›PMID 27572522›Full record

SynthesisClinical rheumatology2016

Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis.

Patompong Ungprasert, Matthew J Koster, Charat Thongprayoon, Kenneth J Warrington

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Clinical rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Thromboembolic events in giant cell arteritis: a scoping review.Annals of medicine and surgery (2012) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Morbidity and Mortality of Large-Vessel Vasculitides.Current rheumatology reports · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Patompong UngprasertDivision of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First street SW, Rochester, MN, 55905, USA. Ungprasert.Patompong@mayo.edu.
Matthew J KosterDivision of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First street SW, Rochester, MN, 55905, USA.
Charat ThongprayoonDepartment of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.
Kenneth J WarringtonDivision of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First street SW, Rochester, MN, 55905, USA.
Mayo Clinic · USBassett Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the possible association between systemic vasculitis and risk of venous thromboembolism (VTE), two investigators independently searched published studies indexed in MEDLINE, EMBASE, and the Cochrane database from inception to April 2016 using the terms for each type of vasculitis in conjunction with the terms for venous thromboembolism. The inclusion criteria were as follows: (1) observational studies published as original studies to evaluate the association between vasculitis and VTE, (2) odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) were provided, and (3) participants without vasculitis were used as comparators for cohort studies and cross-sectional studies while participants without VTE were used as comparators for case-control studies. RevMan 5.3 software was used for the data analysis. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Seven studies investigating the risk of VTE among patients with systemic vasculitis were identified. At least one study was available for three specific forms of vasculitis (polyarteritis nodosa [PAN], granulomatosis with polyangiitis [GPA], and giant cell arteritis [GCA]). An increased risk of VTE was seen in all three vasculitides (GPA, pooled RR 3.94, 95 % CI 1.11-14.01; PAN, pooled RR 3.00, 95 % CI 2.20-4.09; GCA, pooled RR 2.26, 95 % CI 1.38-3.71). This meta-analysis demonstrates that patients with systemic vasculitis may have a significantly increased risk of VTE.

Indexed as

Cross-Sectional StudiesHumansIncidenceRiskVasculitisVenous ThromboembolismEpidemiologyMeta-analysisThromboembolismVasculitis

Identifiers

PMID27572522
OpenAlexW2510766428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.